Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

Rhea-AI Summary

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced a conference call on March 1, 2023, at 8:30 a.m. ET to discuss its financial results for the quarter and year ending December 31, 2022. The call will provide a corporate update and details of the company’s performance. Participants must register in advance through a provided link to access the live call, with an archived webcast available on the company's Investor Relations website. Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders, leveraging innovative research methodologies.

NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, March 1, 2023, to provide a corporate update and discuss details of the Company's financial results for the quarter and year ended December 31, 2022.

To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

FAQ

When will Intra-Cellular Therapies announce its financial results for 2022?

Intra-Cellular Therapies will announce its financial results during a conference call on March 1, 2023.

How can I attend the Intra-Cellular Therapies conference call?

To attend, you must register in advance using the registration link provided in the press release.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

Where can I find the archived webcast of the conference call?

The archived webcast will be available under 'Events & Presentations' on the company's Investor Relations website.